filmov
tv
Dr. Sznol Discusses Advancements in Immunotherapy for RCC
Показать описание
OncLive
cancer
oncology
Рекомендации по теме
0:01:15
Dr. Sznol Discusses Advancements in Immunotherapy for RCC
0:01:00
Dr. Sznol on Immune-Related Toxicities in Melanoma
0:01:02
Dr. Sznol on Immunotherapy in Patients With RCC
0:01:39
Advancements in use of combination drugs in clinical trials: nivolumab, pembrolizumab, and more
0:00:56
Dr. Sznol on the Use of Immunotherapy in Melanoma
0:08:42
Conclusion: Improving Outcomes in Melanoma
0:00:45
Immunotherapy Basics in Melanoma
0:25:37
Panel | Dr.Lillian Siu, Dr.Mario Sznol, Dr.Philippe Bedard, Dr.Anna Spreafico & Dr.Derek Clouthi...
0:10:05
Mario Sznol, et al.
0:58:46
Ask the Expert - A Year in Review: 2022 Research Updates for the Melanoma Community
0:01:50
Dr. Atkins Discusses the Adjuvant Treatment of Melanoma
0:47:41
Treating Melanoma with Immunotherapy, with Jedd Wolchok
0:40:33
Challenges to Precision Medicine for Anti-Cancer Immunotherapy
0:03:22
Take home messages about prostate cancer
0:00:42
Efficacy of Nivolumab in Patients With Melanoma
0:01:35
Giving Immunotherapy before Surgery in Melanoma
0:05:47
Episode 9 -- The Payer Approach to Immunotherapy
0:06:02
Melanoma: Progression After Immunotherapy
0:02:48
Clinical trials investigating the management of immune-related adverse events
0:46:59
Ipilimumab & Antibodies that Stimulate the Immune System
0:06:54
Understanding Immune Checkpoint Inhibitors: Effectiveness, Cancer Types, and Developments
0:07:44
Melanoma: Considerations in Checkpoint Inhibition
0:01:02
Dr. Glitza on Intrathecal Nivolumab Approaches in Leptomeningeal Disease
0:05:59
Targeting NRAS Mutations in Metastatic Melanoma
0:01:15
0:01:00
0:01:02
0:01:39
0:00:56
0:08:42
0:00:45
0:25:37
0:10:05
0:58:46
0:01:50
0:47:41
0:40:33
0:03:22
0:00:42
0:01:35
0:05:47
0:06:02
0:02:48
0:46:59
0:06:54
0:07:44
0:01:02
0:05:59